Back to calendar
Avalo Therapeutics, Inc. (AVTX) Earnings
AVTX reports earnings on Thursday, July 30, 2026
earnings report
July 30, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.58
Actual EPS: $-0.98
EPS surprise: 4.42%
Company overview
Market Cap$1.0B
PriceUSD 19.21
EPS (TTM)-5.82
52-week high24.27
52-week low4.72
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees33